Brainstorm Cell Therapeutics Inc. ^BCLI

Periode	BCLI	NRSN	MTNB	ADIL	CDIO	HCWB	IBO	ACXP	VYNE	ADXN
6M	-54.10 %	-65.53 %	-20.55 %	-2.00 %	-12.94 %	-65.65 %	79.26 %	-69.73 %	-34.15 %	-7.45 %
YTD	-73.83 %	-29.57 %	23.35 %	-77.31 %	-87.68 %	-91.33 %	-57.85 %	-80.18 %	-82.40 %	3.85 %
1Y	-75.44 %	-40.44 %	33.08 %	-77.52 %	-88.94 %	-91.26 %	-44.04 %	-79.82 %	-76.56 %	-0.89 %
3Y	-97.95 %	-42.55 %	-97.21 %	-96.30 %	-88.67 %	-98.04 %	-75.78 %	-95.62 %	-77.97 %	-35.61 %
5Y	-99.28 %	-79.95 %	-98.61 %	-99.48 %	-98.90 %	-99.38 %	-75.78 %	-97.89 %	-99.56 %	-96.87 %
10Y	-98.65 %	-79.95 %	-98.09 %	-99.76 %	-98.90 %	-99.38 %	-75.78 %	-97.89 %	-99.97 %	-96.54 %
From the beginning	-77.87 %	-79.95 %	-98.88 %	-99.76 %	-98.90 %	-99.38 %	-75.78 %	-97.89 %	-99.97 %	-96.54 %

Brainstorm Cell Therapeutics Inc. BCLI